Valuation: Highnoon Laboratories Limited

Market Cap 52.77B 190M 167M 155M 143M 268M 18.15B 272M 1.84B 721M 9B 713M 698M 31.1B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 52.77B 190M 167M 155M 143M 268M 18.15B 272M 1.84B 721M 9B 713M 698M 31.1B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.54x
Free-Float
50.02%
Yield 2026 *
4.52%
Yield 2027 * 5.22%
1 day-0.39%
1 week+0.76%
Current month-0.66%
1 month-0.19%
3 months+4.97%
6 months-4.03%
Current year-2.59%
1 week 954.5
Extreme 954.5
1,057
1 month 921
Extreme 921
1,075
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.8558
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%+0.76%-9.41%+168.68% 190M
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
-0.34%+10.44%+41.46%+35.66% 359B
-0.18%+3.89%+37.48%+42.99% 303B
+1.31%+3.33%+17.63%+17.34% 267B
+0.29%+5.29%-3.03%-38.40% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
Average +0.70%+4.67%+28.46%+66.09% 373.13B
Weighted average by Cap. +0.60%+5.14%+40.94%+79.85%

Financials

2026 *2027 *
Net sales 30.4B 109M 96.03M 89.42M 82.25M 154M 10.45B 157M 1.06B 415M 5.18B 411M 402M 17.91B 34.16B 123M 108M 100M 92.43M 173M 11.75B 176M 1.19B 467M 5.83B 462M 452M 20.13B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
28/07/26 PKR 996.04 -0.39% 6,606
27/07/26 PKR 999.95 +4.03% 34,747
24/07/26 PKR 961.21 -0.45% 10,530
23/07/26 PKR 965.57 -2.06% 17,377
22/07/26 PKR 985.90 -0.26% 7,936
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
996.04PKR
Average target price
1,121.00PKR
Spread / Average Target
+12.55%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock